Sowell Financial Services’s SELLAS Life Sciences SLS Stock Holding History

Sowell Financial Services’s Portfolio SLS Stock Details SLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-10	Closed	–	–	2364
2021 Q1	$0	Buy	+10	New	+$82	﹤0.01%	3285

Other funds holding SLS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Equitable Holdings New York $16.7B AUM 24.23% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Sowell Financial Services's SLS Position: Q2 2021 in Review

Sowell Financial Services sold out of SELLAS Life Sciences (SLS) in Q2 2021, closing a stake of 10 shares.

Sowell Financial Services first reported a position in SLS in Q1 2021 and held it in 1 quarter. The position peaked at $0 in Q1 2021. 29 funds tracked by Wall St. Rank hold SLS as of Q2 2021.

Sowell Financial Services reported no remaining SELLAS Life Sciences position as of Q2 2021 after selling out during the quarter.
Sowell Financial Services sold 10 SELLAS Life Sciences shares in Q2 2021.
Sowell Financial Services first reported a position in SELLAS Life Sciences in Q1 2021 and held it in 1 quarter.
Sowell Financial Services's SELLAS Life Sciences position peaked at $0 in Q1 2021.
29 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.